Growth Equity Opportunities Fund III, LLC - Net Worth and Insider Trading
Growth Equity Opportunities Fund III, LLC Net Worth
The estimated net worth of Growth Equity Opportunities Fund III, LLC is at least $249,385 dollars as of 2024-04-29. Growth Equity Opportunities Fund III, LLC is the 10% Owner of Interleukin Genetics Inc and owns about 55,418,811 shares of Interleukin Genetics Inc (ILIU) stock worth over $249,385. Details can be seen in Growth Equity Opportunities Fund III, LLC's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Growth Equity Opportunities Fund III, LLC has not made any transactions after 2016-07-29 and currently still holds the listed stock(s).
Transaction Summary of Growth Equity Opportunities Fund III, LLC
Growth Equity Opportunities Fund III, LLC Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Growth Equity Opportunities Fund III, LLC owns 2 companies in total, including Strongbridge Biopharma PLC (SBBP) , and Interleukin Genetics Inc (ILIU) .
Insider Ownership Summary of Growth Equity Opportunities Fund III, LLC
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SBBP | Strongbridge Biopharma PLC | 2018-01-01 | 10 percent owner |
| ILIU | Interleukin Genetics Inc | 2016-07-29 | 10 percent owner |
Growth Equity Opportunities Fund III, LLC Latest Holdings Summary
Growth Equity Opportunities Fund III, LLC currently owns a total of 1 stock. Growth Equity Opportunities Fund III, LLC owns 55,418,811 shares of Interleukin Genetics Inc (ILIU) as of July 29, 2016, with a value of $249,385.
Latest Holdings of Growth Equity Opportunities Fund III, LLC
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ILIU | Interleukin Genetics Inc | 2016-07-29 | 55,418,811 | 0.00 | 249,385 |
Holding Weightings of Growth Equity Opportunities Fund III, LLC
Growth Equity Opportunities Fund III, LLC Form 4 Trading Tracker
According to the SEC Form 4 filings, Growth Equity Opportunities Fund III, LLC has made a total of 0 transactions in Interleukin Genetics Inc (ILIU) over the past 5 years. The most-recent trade in Interleukin Genetics Inc is the acquisition of 20,120,724 shares on July 29, 2016, which cost Growth Equity Opportunities Fund III, LLC around $2 Million.
Insider Trading History of Growth Equity Opportunities Fund III, LLC
- 1
Growth Equity Opportunities Fund III, LLC Trading Performance
GuruFocus tracks the stock performance after each of Growth Equity Opportunities Fund III, LLC's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Growth Equity Opportunities Fund III, LLC is 25%. GuruFocus also compares Growth Equity Opportunities Fund III, LLC's trading performance to market benchmark return within the same time period. The performance of stocks bought by Growth Equity Opportunities Fund III, LLC within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Growth Equity Opportunities Fund III, LLC's insider trading performs compared to the benchmark.
Performance of Growth Equity Opportunities Fund III, LLC
Average Return
-91.67%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 50 | 25 | -8.33 | -91.67 | ||
| Relative Return to S&P 500(%) | 49.69 | 27.17 | -13.9 | -105.4 |
Growth Equity Opportunities Fund III, LLC Ownership Network
Ownership Network List of Growth Equity Opportunities Fund III, LLC
Ownership Network Relation of Growth Equity Opportunities Fund III, LLC
Growth Equity Opportunities Fund III, LLC Owned Company Details
What does Strongbridge Biopharma PLC do?
Who are the key executives at Strongbridge Biopharma PLC?
Growth Equity Opportunities Fund III, LLC is the 10 percent owner of Strongbridge Biopharma PLC. Other key executives at Strongbridge Biopharma PLC include 10 percent owner Cdk Associates, L.l.c. , 10 percent owner Caxton Corp , and 10 percent owner Bruce Kovner .
Strongbridge Biopharma PLC (SBBP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Strongbridge Biopharma PLC (SBBP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Strongbridge Biopharma PLC (SBBP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Strongbridge Biopharma PLC (SBBP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Strongbridge Biopharma PLC Insider Transactions
Growth Equity Opportunities Fund III, LLC Mailing Address
Above is the net worth, insider trading, and ownership report for Growth Equity Opportunities Fund III, LLC. You might contact Growth Equity Opportunities Fund III, LLC via mailing address: 1954 Greenspring Drive Suite 600 Timonium Md 21093.
Discussions on Growth Equity Opportunities Fund III, LLC
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
